Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma.
Zaidi SE, Moelker E, Singh K, Mohan A, Salgado MA, Essibayi MA, Hotchkiss K, Shen S, Lee W, Sampson J, Khasraw M. Zaidi SE, et al. Among authors: shen s. BioDrugs. 2023 Jul;37(4):489-503. doi: 10.1007/s40259-023-00598-2. Epub 2023 May 31. BioDrugs. 2023. PMID: 37256535 Review.
Promising vaccines for treating glioblastoma.
Swartz AM, Shen SH, Salgado MA, Congdon KL, Sanchez-Perez L. Swartz AM, et al. Expert Opin Biol Ther. 2018 Nov;18(11):1159-1170. doi: 10.1080/14712598.2018.1531846. Epub 2018 Oct 15. Expert Opin Biol Ther. 2018. PMID: 30281978 Review.
CAR T cells and checkpoint inhibition for the treatment of glioblastoma.
Shen SH, Woroniecka K, Barbour AB, Fecci PE, Sanchez-Perez L, Sampson JH. Shen SH, et al. Expert Opin Biol Ther. 2020 Jun;20(6):579-591. doi: 10.1080/14712598.2020.1727436. Epub 2020 Feb 17. Expert Opin Biol Ther. 2020. PMID: 32027536 Free PMC article. Review.
Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma.
Suryadevara CM, Desai R, Abel ML, Riccione KA, Batich KA, Shen SH, Chongsathidkiet P, Gedeon PC, Elsamadicy AA, Snyder DJ, Herndon JE 2nd, Healy P, Archer GE, Choi BD, Fecci PE, Sampson JH, Sanchez-Perez L. Suryadevara CM, et al. Oncoimmunology. 2018 Feb 21;7(6):e1434464. doi: 10.1080/2162402X.2018.1434464. eCollection 2018. Oncoimmunology. 2018. PMID: 29872570 Free PMC article.
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts.
Suryadevara CM, Desai R, Farber SH, Choi BD, Swartz AM, Shen SH, Gedeon PC, Snyder DJ, Herndon JE 2nd, Healy P, Reap EA, Archer GE, Fecci PE, Sampson JH, Sanchez-Perez L. Suryadevara CM, et al. Among authors: shen sh. Clin Cancer Res. 2019 Jan 1;25(1):358-368. doi: 10.1158/1078-0432.CCR-18-1211. Epub 2018 Nov 13. Clin Cancer Res. 2019. PMID: 30425092 Free PMC article.
Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease.
Kemeny HR, Elsamadicy AA, Farber SH, Champion CD, Lorrey SJ, Chongsathidkiet P, Woroniecka KI, Cui X, Shen SH, Rhodin KE, Tsvankin V, Everitt J, Sanchez-Perez L, Healy P, McLendon RE, Codd PJ, Dunn IF, Fecci PE. Kemeny HR, et al. Among authors: shen sh. Clin Cancer Res. 2020 Mar 1;26(5):1141-1151. doi: 10.1158/1078-0432.CCR-18-3486. Epub 2019 Nov 19. Clin Cancer Res. 2020. PMID: 31744830 Free PMC article.
8,149 results